Next report date
Report period
Q1 2024
EPS estimate
−0.05USD
Revenue estimate
12.00 MUSD
−26.94 MUSD
33.88 MUSD
6.33 M
Om CASI Pharmaceuticals, Inc.
Sektor
Bransch
VD
Wei-Wu He
Webbplats
Huvudkvarter
Beijing
Employees (FY)
243
Grundat
1991
ISIN
KYG1933S1012
FIGI
BBG01DSTT3T7
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
